Healthcare -
Biotechnology - NASDAQ - US
$ 6.43
-2.43 %
$ 2.47 B
Market Cap
-3.8
P/E
RXRX - COST OF REVENUE
Cost of Revenue RXRX - Recursion Pharmaceuticals, Inc.
42.6 M
LAST VALUE
116.28%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR